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Abstract
Objective: Preeclampsia occurs in about 4 per cent of pregnancies worldwide, and may have particularly serious
consequences for women in Africa. Studies in western countries have shown that women with preeclampsia in one
pregnancy have a substantially increased risk of preeclampsia in subsequent pregnancies. We estimate the
recurrence risks of preeclampsia in data from Northern Tanzania.
Methods: A prospective cohort study was designed using 19,811 women who delivered singleton infants at a
hospital in Northern Tanzania between 2000and2008. A total of 3,909 women were recorded with subsequent
deliveries in the hospital with follow up through 2010. Adjusted recurrence risks of preeclampsia were computed
using regression models.
Results: The absolute recurrence risk of preeclampsia was25%, which was 9.2-fold (95% CI: 6.4 - 13.2) compared
with the risk for women without prior preeclampsia. When there were signs that the preeclampsia in a previous
pregnancy had been serious either because the baby was delivered preterm or had died in the perinatal period, the
recurrence risk of preeclampsia was even higher. Women who had preeclampsia had increased risk of a series of
adverse pregnancy outcomes in future pregnancies. These include perinatal death (RR= 4.3), a baby with low birth
weight (RR= 3.5), or a preterm birth (RR= 2.5). These risks were only partly explained by recurrence of
preeclampsia.
Conclusions: Preeclampsia in one pregnancy is a strong predictor for preeclampsia and other adverse pregnancy
outcomes in subsequent pregnancies in Tanzania. Women with previous preeclampsia may benefit from close follow-
up during their pregnancies.
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Introduction
Preeclampsia is associated with increased risk of maternal
and perinatal morbidity and mortality, as well as long-term
complications [1]. Preeclampsia is a major contributor to death
and disability among women of reproductive age in many low
income countries [2]. A review of preeclampsia studies in
developing countries found prevalence ranging from 1.8% to
16.7% [3]. The highest figures are approximately 3-fold of the
global prevalence of 4% [4].Preeclampsia remains a major
public health problem in sub Saharan Africa.
Several risk factors for preeclampsia have been well
documented [5,6]. These include first pregnancy, a history of
preeclampsia, high maternal age, long inter-pregnancy interval,
multiple pregnancy, gestational diabetes, chronic hypertension,
family history of preeclampsia and history of preterm delivery.
High body weight has been documented to be a risk factor also
in Africa [7].
High recurrence risk of preeclampsia has been reported from
high-income countries[8,9].Recurrent preeclampsia is also
associated with adverse pregnancy outcomes in the
PLOS ONE | www.plosone.org 1 November 2013 | Volume 8 | Issue 11 | e79116
subsequent pregnancies such as preterm birth, low birth
weight, perinatal death and chronic hypertension [10,11].
There are limited data about recurrence of preeclampsia in
low-income countries including Tanzania. Some studies in
Africa have reported recurrence risks of hypertension [12,13].
However, these studies were based on cross-sectional data
and had limited sample size.
Information on recurrence risk may help clinicians in decision
making, for example in counselling women with previous
history of preeclampsia who desire to have next pregnancy and
in the clinical follow-up of these pregnancies. This study used
prospective data from a hospital based registry in Tanzania to
estimate the recurrence risk of preeclampsia.
Materials and Methods
A prospective cohort study was designed using maternally
linked data from Kilimanjaro Christian Medical Centre (KCMC)
medical birth registry. A unique maternal hospital identification
number was used to link records of subsequent deliveries of
the same mother.
KCMC is one of the four zone referral hospitals in Tanzania,
located in Moshi urban district, Kilimanjaro region in the
Northern Tanzania. The centre receives deliveries from the
nearby communities within the region and referred cases from
other regions (i.e. from more distant areas). We excluded
women who were referred from more distant areas for various
medical reasons, since medical problems could be
overrepresented in our data among women from more distant
areas. We also excluded women with multiple gestations. The
study population was women from the natural catchment area
of KCMC with singleton deliveries.
The medical registry collects information from all women who
deliver at the department of obstetrics and gynecology within
24 hours after delivery or as soon as mothers have recovered
in case of complicated deliveries. Trained nurse midwives
carried out daily interviews using a standardized questionnaire
to collect the registry data. In addition, mothers admitted were
asked to provide their antenatal (ANC) cards from which
relevant data were abstracted. Furthermore, data were
abstracted from patient case notes housed in the medical
records.The details of data collection methods have been
described elsewhere [14]. In summary, data captured in the
standardized questionnaire include parents’ socio-demographic
characteristics, maternal health before and during present
pregnancy, complications during labour and delivery, and
information from the interview regarding the mother’s previous
pregnancies. In addition, information on the baby such as sex,
date and time of delivery, birth weight, gestational age,
presentation, length and head circumference, plurality, mode of
delivery, abnormal conditions (birth defects, injuries or other
diseases), Apgar score, and child status in four categories: 1)
live born 2) live born transferred to NCU 3) neonatal death in
labour ward, 4) stillborn were recorded.
We constructed our cohort using 19,811 (736; 3.7% with
preeclampsia and 19,075 without preeclampsia) women who
were recorded for the first time with a singleton delivery at
KCMC in the period 2000–2008.The women were then
followed for any subsequent birth sin the hospital up to 2010
using the unique maternal hospital number. The median follow-
up window period was 6.5 years. We excluded women who
were referred from rural areas for various medical reasons and
those with multiple gestations. Our final study sample was
3,909 (19.7%) of women whom were recorded with at least one
or more birth during the follow-up period (Figure 1). These
women had a total of 4,503 additional pregnancies in the
follow-up period. We studied recurrence of preeclampsia from
the first recorded pregnancy to any of the subsequent
pregnancies.
In order to ensure that there was a true linkage between
pregnancies of the same mother, we used various validation
criteria such as; 1) matching the year of birth in the linked data
with the same year recorded in the reproductive history data
based on maternal recall and interview after each birth; 2) birth
interval calculated from birth dates were cross-checked against
the recorded change in maternal age for 2 consecutive
deliveries, and a discrepancy of more than 2 years led to
exclusion from the data.
Our ability to capture subsequent births at the hospital may
have been incomplete. By using reproductive history interviews
conducted at each delivery we were able to calculate the
expected proportion of women with a subsequent birth within
the follow-up time. Assuming symmetry of the distribution of
births within the period 2000 to 2010, we constructed a
“backwards cohort” by identifying the last birth of 21,086
mothers in the period 2002-2010. A total of 7,191 women
(34.1%) reported a prior birth in the period 2000-2010.
Comparing this estimate with the 19.7% who actually were
observed with a subsequent birth we estimated that the
completeness of our follow-up was 58% (19.7/34.1).
The main outcome variable was relative risk and recurrence
risk of preeclampsia in subsequent pregnancies. Preeclampsia
was in our study defined as increased blood pressure to a level
of 140 mmHg systolic blood pressure or more and diastolic
blood pressure 90 mmHg or above) recorded after 20 weeks’ of
gestationage combined with proteinuria (≥300mg in a 24 hours
urine collection) [15].Recurrence of preeclampsia was defined
as repetition of a preeclampsia diagnosis in a subsequent
pregnancy.
Data were analyzed using SPSS package version 18.0
(SPSS Inc., in Chicago, Illinois, USA) and Stata version 12.0.
Student’s t-test was used for comparison of continuous
variables, and comparison of proportions was performed by
chi-square (χ2).Log-binomial regression model was used to
estimate the relative risk and recurrence risk for preeclampsia
with95% confidence intervals (CIs).A p-value of less than 5%
was considered statistically significant. The recurrence of
preeclampsia was estimated from the first to any of the
subsequent pregnancies. We used mothers as the primary unit
for our analysis and conducted a clustered analysis technique
with robust estimation of variances to account for the
correlation between repeated observations of the same woman
in the follow-up period.
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Ethics Statement
This study was approved by the Kilimanjaro Christian
Medical University college ethics committee and by the
National Institute of Medical Research of Tanzania. For
practical reasons, the midwives give oral information
individually to each mother and then asked if is willing to
participate. Participation and further interviewing was then
based on oral consent. Following consent, the mother could
still choose not to reply to single question. In order to document
the consent process, the birth registry has an instruction
manual for registration of deliveries in the registry. This manual
contains the standard operating procedures on how to conduct
the interview and also has a description of the basic rules
including ethical guidelines such as consent process. The
consent procedure was approved by the ethics committee as it
was part of the study protocol. Approvals were given by the
local IRB at the hospital and by the Tanzanian Ministry of
Health. Since the project received Norwegian funding, the
protocol was also submitted to a Norwegian IRB which stated
that they did not need to approve the project.
Results
Our study included a total of 3,909 women who were
recorded in the registry with at least two singleton births during
the study period. Among these women, 137 (3.5%) had
preeclampsia in their first pregnancy. Maternal and fetal
characteristics of the first pregnancy are shown in Table
1.Women with preeclampsia in their first recorded pregnancy
were older (P=0.001) and had shorter gestation age at delivery
(P<0.001) compared with women who did not have
preeclampsia. Furthermore, women with preeclampsiahad
Figure 1.  Schematic presentation of the cohort follow-up. Data from the Kilimanjaro Christian Medical Centre (KCMC)
birth registry.  
doi: 10.1371/journal.pone.0079116.g001
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significantly higher rates of chronic hypertension, perinatal
death, induced labour, preterm birth and were more likely
deliver babies with low birth weight. The 3,909 women in our
cohort had a total of 4,503 subsequent pregnancies recorded in
our data that were used to study recurrence.
Table 1. Socio-demographic and obstetric factors of the
3,909 women in the cohort.
 Outcome in the 1strecorded pregnancy
Maternal characteristics
in 1strecorded pregnancy
No preeclampsia n
(%) Preeclampsia n (%)    P- value*
Total 3,772(96.5) 137 (3.5)  
Education level:   0.04
≤12 years 2,514 75 (2.8)  
>12 years 1,258 62 (4.7)  
Pregnancy Body Mass
Index (BMI)∞   0.09
Underweight (<18.5) 499 22 (4.2)  
Normal (18.5-24.9) 198 5 (2.5)  
Overweight (25-29.9) 276 7 (2.5)  
Obese (≥30) 202 14 (6.5)  
Number of ANC visits:   0.24
<5 2,216 87 (3.8)  
≥5 1,556 50 (3.1)  
Gestation hypertension   <0.001
Yes 14 4 (22.0)  
No 3,758 133 (3.4)  
Chronic hypertension   <0.001
Yes 36 11 (23.4)  
No 3,736 126 (3.3)  
Diabetes    
Yes 5 2 (28.6) <0.001
No 3,767 135 (3.5)  
Induced labour   0.003
Yes 1,447 70 (4.6)  
No 2,325 678 (2.8)  
Caesarian section   0.24
Yes 1,199 50 (4.0)  
No 2,573 87 (3.3)  
Preterm birth§   <0.001
Yes 462 47 (9.2)  
No 3,019 80 (2.6)  
Low birth weight 518 56 (9.8) <0.001
Yes 3,254 81 (2.5)  
No    
Perinatal death   <0.001
Yes 245 26 (9.6)  
No 3,527 111 (3.1)  
Maternal age: mean (SD) 25.9 (4.9)† 27.4 (4.9)† 0.001
Gestational age at
delivery 38.9 (2.7) 
† 37.0 (3.3) <0.001
*. Chi-square tests for heterogeneity except of a t-test for mean maternal age
†. SD – Standard Deviation
§. Does not add to total because 301 (7.7%) missed gestational age
∞Does not add to total because of missing BMI variables (weight or height)
doi: 10.1371/journal.pone.0079116.t001
First, we studied how the risk of preeclampsia in a future
pregnancy was determined by maternal and fetal conditions of
the first recorded pregnancy (Table 2). The absolute
recurrence risk of preeclampsia was 24.6%, which amounted to
a 9.2-fold relative risk (95% CI: 6.4 - 13.2). In a sub analysis,
we stratified the recurrence risk for preeclampsia by order of
subsequent pregnancy. The recurrence risk of preeclampsia in
the second pregnancy was 10.3-fold (95% CI: 7.3-14.8), for
third, fourth or fifth pregnancy combined, the risk was 5.0-fold
(95% CI: 2.1-12.0). These relative risks were, however, not
significantly different (p=0.10).
Another factor that may modify the recurrence risk is the
inter-pregnancy interval, which also will be higher for
recurrence to 3rd, 4thor 5th pregnancy. The recurrence risk for a
new pregnancy that started within the next four years was 10.0-
fold (95% CI: 6.4-15.7). This was not significantly different from
an estimated 8.3-fold risk (95% CI: 5.0-13.6) for a new
pregnancy that started after more than four years.
Several other maternal conditions in the first pregnancy
showed associations with increased risk of preeclampsia in a
subsequent pregnancy that was similar to the recurrence risk.
These included chronic hypertension (RR= 8.9; 95% CI: 5.7
-13.8), gestational hypertension (RR= 9.8; 95% CI: 4.9 -19.1)
and diabetes mellitus (RR= 8.4; 95% CI: 2.7 - 26.3).
Table 2. Risk of preeclampsia by maternal characteristics in
first pregnancy.
Characteristic of Preeclampsia in subsequent pregnancy
First pregnancy* At risk n (%) RR (95 % CI)† P-value
Preeclampsia     
Yes 171 42 (24.6) 9.2 (6.4 - 13.2) <0.001
No 4,332 103 (2.4) Reference  
Chronic hypertension     
Yes 63 18 (28.6) 8.9 (5.7 - 13.8) <0.001
No 4,440 127 (2.9) Reference  
Gestational hypertension     
Yes 25 9(36.0) 9.8 (4.9 - 19.1) <0.001
No 4,478 136(3.0) Reference  
Diabetes Mellitus     
Yes 8 2 (25.0) 8.4(2.7 - 26.3) <0.001
No 4,495 143 (3.2) Reference  
Preterm birth§     
Yes 610 45 (7.4) 3.1 (2.1 - 4.7) <0.001
No 3,544 87 (2.5) Reference  
Low birth weight (<2500g)     
Yes 689 51 (7.4) 3.1 (2.1 - 4.5) <0.001
No 3,814 93 (2.4) Reference  
Perinatal death     
Yes 341 36(10.6) 3.9 (2.7 - 5.9) <0.001
No 4,162 109 (2.6) Reference  
*Adjusted for maternal age and maternal education in Log-binomial model
accounting for correlation between successive deliveries of the same mother.
† RR=Adjusted Relative Risk, CI= Confidence Interval
§ Does not add to total because 349 (7.8%) missed gestational age
doi: 10.1371/journal.pone.0079116.t002
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Fetal outcomes of first pregnancy were also associated with
the risk of preeclampsia in a subsequent pregnancy. A preterm
birth increased the risk 3.1-fold (95% CI: 2.1 - 4.7), low birth
weight 3.1-fold (95% CI: 2.1 - 4.5) and perinatal death 3.9-fold
(95% CI: 2.9 - 5.9).
These risks depended, however, on the presence of
preeclampsia in the first pregnancy. Figure 2 shows the risks of
preeclampsia in a subsequent pregnancy by whether there was
preterm birth or preeclampsia or both in the first pregnancy.
The highest risk was seen when a woman had a first
pregnancy with preeclampsia that was delivered preterm,
perhaps because serious preeclampsia has higher recurrence
risk (absolute recurrence risk of 35.5%). Slightly lower risk was
seen after a first pregnancy with preeclampsia that was
delivered at term. A preterm birth without any recorded
preeclampsia still increased the risk of preeclampsia in a future
pregnancy. Similar patterns of risk were seen when
preeclampsia in first pregnancy was combined with low birth
weight or perinatal death. The effects of low birth weight were
similar when we restricted to term births.
High body weight is a known risk factor for preeclampsia. We
explored whether body weight before first pregnancy was
associated with risk of recurrence of preeclampsia. Women
who went on to have two pregnancies, both affected by
preeclampsia, had an average weight before the first
pregnancy of 66.3 kilograms. This was not different from 65.6
kilograms for women who had preeclampsia only in the first of
two pregnancies (Figure 3). There was also little difference for
these two groups in weight before the second pregnancy.
Although higher weight is associated with preeclampsia, future
recurrent preeclampsia could not be predicted by high body
weight of a woman in our data.
We then went on to study the effect of preeclampsia in the
first pregnancy on the risks for babies of future pregnancies
(Table 3). For women who had preeclampsia in their first
pregnancy, the total risk of preterm birth, low birth weight or
perinatal death in a subsequent pregnancy increased 2.5-fold,
3.5-fold and 4.3-fold, respectively. As seen from the previous
analysis, this could be partly explained by recurrence of
preeclampsia. When we adjusted for a diagnosis of
preeclampsia in the subsequent pregnancy (in addition to the
other adjustments) we expect to remove the contribution of
recurrent preeclampsia to these risks. The new estimates were
lower, but still two- to three-fold with confidence intervals
excluding one. We denoted these risks “direct risks” in the table
to indicate that these associations do not appear to work
through recurrence of a diagnosis of preeclampsia.
Discussion
Our data show that preeclampsia is not only a serious
complication of a particular pregnancy in Tanzania, but also a
strong predictor for preeclampsia and other adverse outcomes
in future pregnancies. Women with preeclampsia in a previous
pregnancy had a 9-fold increased risk of preeclampsia. The
absolute recurrence risk was as high as 25%.In addition, when
there were signs that preeclampsia in the previous pregnancy
had serious consequences; the risk of preeclampsia in future
pregnancies was even higher.
Cross-sectional studies in Africa have reported recurrence
risks of preeclampsia and hypertension, ranging from15.8% to
36% [13,16]. The estimated recurrence risk of preeclampsia in
our prospective study falls within this range. The absolute
recurrence risk of preeclampsia observed in our study was
higher than estimates from studies in western countries [11,17].
For example, studies in Scandinavian countries have found
recurrence risks in the range of 13% to 15% [9,18-20].Other
studies in western countries have reported a recurrence of
preeclampsia of 14% [21,22]. A recent study in Israel reported
the recurrence risk of preeclampsia as low as 6% [15].Our
estimate from Tanzania was, however, not very different from
28% reported in USA [10]. Possible explanations for these
differences in recurrence may be the differences in prevalence
of risk factors for preeclampsia between the studied
populations such as chronic hypertension and diabetes or
differences in diagnosis. Lower absolute risk of recurrence
could also be attributed to heightened antepartum surveillance
system for mothers with previous preeclampsia who are
considered as high risk group by health care providers. It is
also possible that poor management of preeclampsia in one
pregnancy increased the risk of preeclampsia in the next
pregnancy in some countries.
We show in our data that the recurrence risk varies by
assumed severity of preeclampsia and by presence of chronic
conditions like hypertension and diabetes. Similarly, Mamomed
and colleagues [12] reported that history of chronic
hypertension was associated with eleven-fold increased risk of
preeclampsia. Other studies also report high recurrence risk
after a preeclamptic pregnancy that was delivered preterm
[11,15,20]. One possible reason for discrepancy between our
estimated recurrence risk and those of some others studies
may be differences in the proportion of serious preeclampsia
cases included in the studies. Our hospital data may contain
more women with very serious preeclampsia than in the
general population.
We found that a history of preeclampsia was associated not
only with future risk of preeclampsia but also withadverse
outcomes for future babies such as preterm birth, perinatal
death and low birth weight. Our finding is in agreement with
previous studies [11,15,20].We also show that this increased
risk is not only due to the effects of recurrent preeclampsia.
Women should receive counselling after having had
preeclampsia about the future risks. There is also apotential to
use the relatively frequent antenatal visits in this population to
detect the development of preeclampsia in women who had
preeclampsia in a previous pregnancy and who would benefit
from closer clinical monitoring. Measures to prevent recurrent
preeclampsia have been proposed [8,23], but the utility of each
of these needs to be studied in an African context.Our study
also suggests benefits of closer clinical follow up for the babies
of future pregnancies.
Our study had a number of limitations that need to be
considered. First, the possibility of selection bias is an inherent
problem in hospital-based studies as compared to population-
based studies. Our study excluded all women who were
Recurrence Risk of Preeclampsia
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Figure 2.  Conditions of the first pregnancy (preeclampsia in combination with preterm birth, low birth weight or
perinatal death) and the risk of preeclampsia in the next pregnancy.  
doi: 10.1371/journal.pone.0079116.g002
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referred for various medical conditions. We found no effect of
socio-economic status on recurrence risks. Still, our study may
not be representative of the whole population in the area.
Second, a loss to follow-up estimate of 42%indicates that a
high proportion of women were not recorded with their
subsequent pregnancies. These women may have had
different risk characteristics from those who were followed up.
The proportion of women who showed up for a future birth
were, however, not very different for women with previous
preeclampsia (19%) and women with no previous preeclampsia
(20%). We also repeated our analysis by excluding all women
who were referred for various medical reasons in their second
pregnancy to minimize selection bias due to referral of future
births. The relative risk of recurrence of preeclampsia remained
unaffected, (9.2 vs. 8.7). This gave us some degree of
assurance that the association is not much affected by bias
due to selection in the follow-up.
Third, our ability to identify future births of the same woman
by record linkage may be imperfect. We excluded women who
did not meet several matching criteria. Errors in hospital
numbers and failed linkages may be one source of loss of
follow-up in the present study. Such errors should, however, be
random, and not affect our results.
Our study also had several strengths. To our knowledge, this
is the largest prospective cohort to study recurrence risk of
preeclampsia in Tanzania, and perhaps even in sub Saharan
Africa. Our study provided estimates that seemed to be
consistent with the literature. By linking maternal and sibling
records, we were able to calculate recurrence risks of
preeclampsia, which would not be reliable with cross sectional
data. Our study was not affected by recall bias.
The KCMC birth registry used a standardized data collection
mechanism with the same staff over more than a decade.
Detailed information regarding reproductive outcomes of
successive pregnancies of each woman was captured by
linking birth records using a unique maternal identification
number and other specific matching criteria.
Figure 3.  Mean of mother’s body weight before the first pregnancy for women with two recorded pregnancies depending
on whether each pregnancy was affected by preeclampsia.  
doi: 10.1371/journal.pone.0079116.g003
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In conclusion, preeclampsia in one pregnancy was a strong
risk factor for preeclampsia in future pregnancies in Tanzania.
Table 3. Preeclampsia and risk of adverse fetal outcomes
in a future pregnancy.
  Risk in future pregnancy
Outcome in
future
pregnancy
Preeclampsia
in 1st
pregnancy At risk n (%)
RR(95 % CI)*
“Total risk”
RR (95% CI) †
“Direct risk”
Preterm
birth§ Yes 162 28 (17.3) 2.5 (1.7-3.6) 1.8 (1.2-2.7)
 No 4,023 299 (7.4) Ref. Ref.
Low birth
weight Yes 171 24 (14.0) 3.5(2.2-5.4) 1.8 (1.1-3.1)
 No 4,329 174 (4.0) Ref. Ref.
Perinatal
death Yes 171 22 (12.9) 4.3(2.7-6.8) 3.1(1.8-5.3)
 No 4,332 125 (2.9) Ref. Ref.
*. “Total” relative risk adjusted for maternal age, maternal education, and chronic
hypertension in a future pregnancy using a log-binomial model and accounting for
correlation between successive deliveries of the same mother.
†. “Direct” relative risk adjusted also for preeclampsia in a future pregnancy to
remove the contribution working indirectly through recurrence of preeclampsia
§. Lower numbers because of missing gestational age information
doi: 10.1371/journal.pone.0079116.t003
The risk increased by severity of the condition. Preeclampsia
also increased the risk for the babies of future pregnancies.
Our study suggests that improved clinical counselling and
management of pregnant women with a history of
preeclampsia may benefit women in Tanzania and their babies.
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